Invention Grant
![Pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives useful in the treatment of psoriasis and systemic lupus erythematosus](/docs/US/2024-02-06/US11891400B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives useful in the treatment of psoriasis and systemic lupus erythematosus
-
Application No.: US17268644Application Date: 2019-09-04
-
Publication No.: US11891400B2Publication Date: 2024-02-06
- Inventor: Zhaogen Chen , Jon Andre Erickson , Gaiying Zhao
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Robert D. Shereda
- International Application: PCT/US2019/049448 2019.09.04
- International Announcement: WO2020/055636A 2020.03.19
- Date entered country: 2021-02-16
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D487/02 ; A61P17/06 ; A61P37/00
![Pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives useful in the treatment of psoriasis and systemic lupus erythematosus](/abs-image/US/2024/02/06/US11891400B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides a compound of Formula I: wherein R is methyl or ethyl; or a pharmaceutically acceptable salt thereof useful for treating psoriasis or systemic lupus erythematosus.
Public/Granted literature
Information query
